A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

被引：0
|
作者：
Byeong-Bae Park
Joon Oh Park
Hyo Rak Lee
Jeeyun Lee
Dong Wook Choi
Seong-Ho Choi
Jin Seok Heo
Jong Kyun Lee
Kyu Taek Lee
Do Hoon Lim
Young Suk Park
Ho-Yeong Lim
Won Ki Kang
Keunchil Park
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
[4] Sungkyunkwan University School of Medicine,Division of Gastroenterology, Department of Medicine, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Gemcitabine; Capecitabine; Pancreatic cancer; CA19-9;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 494
页数：5
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Park, Byeong-Bae
    Park, Joon Oh
    Lee, Hyo Rak
    Lee, Jeeyun
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin Seok
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Do Hoon
    Park, Young Suk
    Lim, Ho-Yeong
    Kang, Won Ki
    Park, Keunchil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 489 - 494
  • [2] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [3] Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma - Results of a phase II trial
    Dragovich, Tomislav
    Burris, Howard, III
    Loehrer, Patrick
    Von Hoff, Daniel D.
    Chow, Sherry
    Stratton, Steven
    Green, Sylvan
    Obregon, Yrma
    Alvarez, Irene
    Gordon, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 157 - 162
  • [4] Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial
    Hess, V
    Salzberg, M
    Borner, M
    Morant, R
    Roth, AD
    Ludwig, C
    Herrmann, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 66 - 68
  • [5] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [6] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [7] Phase II trial of bevacizurnab plus gemcitabine in patients with advanced pancreatic cancer
    Kindler, HL
    Friberg, G
    Singh, DA
    Locker, G
    Nattam, S
    Kozloff, M
    Taber, DA
    Karrison, T
    Dachman, A
    Stadler, WM
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8033 - 8040
  • [8] GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL
    Hess, V.
    Pestalozzi, B.
    Ludwig, C.
    Winterhalder, R.
    Lohri, A.
    Jost, L.
    Widmer, L.
    Lee, L.
    Stillhart, P.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 181 - 181
  • [9] Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx): A randomized phase II trial in advanced pancreatic cancer.
    Heinemann, V
    Hoehler, T
    Seipelt, G
    Wein, A
    Golf, A
    Mahlberg, R
    Schmid, B
    Boeck, S
    Neugebauer, S
    Hochhaus, A
    Grosshadern, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 315S - 315S
  • [10] Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma
    Scheithauer, W.
    Kornek, G.
    Prager, G.
    Stranzl, N.
    Laengle, F.
    Schindl, M.
    Friedl, J.
    Klech, J.
    Roethlin, S.
    Zielinski, C.
    ANNALS OF ONCOLOGY, 2015, 26
12345